XML 27 R16.htm IDEA: XBRL DOCUMENT
v3.26.1

Fair Value Measurements | 6 Months Ended
--- | ---
Jun. 30, 2026
Fair Value Disclosures [Abstract] |
Fair Value Measurements | Fair Value Measurements The following tables present estimated fair values of the Company’s financial instruments as of the period indicated, whether or not recognized or recorded in the consolidated balance sheets at the period indicated:
| June 30, 2026 |  | Fair Value Measurements Using
| Carrying Value |  | Estimated Fair Value |  | Level 1 |  | Level 2 |  | Level 3
| (dollars in thousands; unaudited)
Financial assets |  |  |  |  |  |  |  |  |
Cash and due from banks | $ | 48,088 |  |  | $ | 48,088 |  |  | $ | 48,088 |  |  | $ | — |  |  | $ | — |
Interest earning deposits with other banks | 960,360 |  |  | 960,360 |  |  | 960,360 |  |  | — |  |  | — |
Investment securities | 45,246 |  |  | 45,360 |  |  | — |  |  | 45,360 |  |  | — |
Other investments | 14,177 |  |  | 14,177 |  |  | — |  |  | 12,356 |  |  | 1,821 |
Loans held for sale | 107,838 |  |  | 107,838 |  |  | — |  |  | 107,838 |  |  |
Loans receivable | 4,208,270 |  |  | 4,197,259 |  |  | — |  |  | — |  |  | 4,197,259 |
Accrued interest receivable | 20,937 |  |  | 20,937 |  |  | — |  |  | 20,937 |  |  | — |
Financial liabilities |  |  |  |  |  |  |  |  |
Deposits | $ | 4,861,898 |  |  | 4,836,352 |  |  | $ | — |  |  | $ | 4,836,352 |  |  | $ | — |
Subordinated debt | 44,518 |  |  | 44,274 |  |  | — |  |  | 44,274 |  |  | — |
Junior subordinated debentures | 3,594 |  |  | 3,547 |  |  | — |  |  | 3,547 |  |  | — |
Accrued interest payable | 2,178 |  |  | 2,178 |  |  | — |  |  | 2,178 |  |  | — |
| December 31, 2025 |  | Fair Value Measurements Using
| Carrying Value |  | Estimated Fair Value |  | Level 1 |  | Level 2 |  | Level 3
| (dollars in thousands; unaudited)
Financial assets |  |  |  |  |  |  |  |  |
Cash and due from banks | $ | 34,241 |  |  | $ | 34,241 |  |  | $ | 34,241 |  |  | $ | — |  |  | $ | — |
Interest earning deposits with other banks | 702,729 |  |  | 702,729 |  |  | 702,729 |  |  | — |  |  | — |
Investment securities | 48,247 |  |  | 48,742 |  |  | — |  |  | 48,742 |  |  | — |
Other investments | 12,837 |  |  | 12,837 |  |  | — |  |  | 10,666 |  |  | 2,171 |
Loans held for sale | 71,216 |  |  | 71,216 |  |  | — |  |  | 71,216 |  |  |
Loans receivable, net | 3,749,531 |  |  | 3,738,084 |  |  | — |  |  | — |  |  | 3,738,084 |
Accrued interest receivable | 18,613 |  |  | 18,613 |  |  | — |  |  | 18,613 |  |  | — |
Financial liabilities |  |  |  |  |  |  |  |  |
Deposits | $ | 4,144,199 |  |  | $ | 4,130,842 |  |  | $ | — |  |  | $ | 4,130,842 |  |  | $ | — |
Subordinated debt | 44,443 |  |  | 44,132 |  |  | — |  |  | 44,132 |  |  | — |
Junior subordinated debentures | 3,593 |  |  | 3,719 |  |  | — |  |  | 3,719 |  |  | — |
Accrued interest payable | 1,435 |  |  | 1,435 |  |  | — |  |  | 1,435 |  |  | — |
The Company measures and discloses certain assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (that is, not a forced liquidation or distressed sale). GAAP establishes a consistent framework for measuring fair value and disclosure requirements about fair value measurements. Among other things, the accounting standard requires the reporting entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s estimates for market assumptions. These two types of inputs create the following fair value hierarchy: •Level 1 – Quoted prices in active markets for identical instruments. An active market is a market in which transactions occur with sufficient frequency and volume to provide pricing information on an ongoing basis. A quoted price in an active market provides the most reliable evidence of fair value and shall be used to measure fair value whenever available. •Level 2 – Observable inputs other than Level 1 including quoted prices in active markets for similar instruments, quoted prices in less active markets for identical or similar instruments, or other observable inputs that can be corroborated by observable market data. •Level 3 – Unobservable inputs supported by little or no market activity for financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation; also includes observable inputs from nonbinding single dealer quotes not corroborated by observable market data. The estimated fair value amounts of financial instruments have been determined by the Company using available market information and appropriate valuation methodologies. However, considerable judgment is required to interpret data to develop the estimates of fair value. Accordingly, the estimates presented herein are not necessarily indicative of the amounts the Company could realize at a future date. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts. In addition, reasonable comparability between financial institutions may not be likely due to the wide range of permitted valuation techniques and numerous estimates that must be made given the absence of active secondary markets for certain financial instruments. This lack of uniform valuation methodologies also introduces a greater degree of subjectivity to these estimated fair values. Items measured at fair value on a recurring basis – The following fair value hierarchy table presents information about the Company’s assets that are measured at fair value on a recurring basis at the dates indicated:
| Level 1 |  | Level 2 |  | Level 3 |  | Total Fair Value
| (dollars in thousands; unaudited)
June 30, 2026 |  |  |  |  |  |  |
Available-for-sale |  |  |  |  |  |  |
U.S. Agency collateralized mortgage obligations | $ | — |  |  | $ | 27 |  |  | $ | — |  |  | $ | 27 |
| $ | — |  |  | $ | 27 |  |  | $ | — |  |  | $ | 27 |
December 31, 2025 |  |  |  |  |  |  |
Available-for-sale |  |  |  |  |  |  |
U.S. Agency collateralized mortgage obligations | $ | — |  |  | $ | 29 |  |  | $ | — |  |  | $ | 29 |
| $ | — |  |  | $ | 29 |  |  | $ | — |  |  | $ | 29 |
The following methods were used to estimate the fair value of the class of financial instruments above: Investment securities – The fair value of securities is based on quoted market prices, pricing models, quoted prices of similar securities, independent pricing sources and discounted cash flows. Limitations: The fair value estimates presented herein are based on pertinent information available to management as of June 30, 2026 and December 31, 2025. The factors used in the fair values estimates are subject to change subsequent to the dates the fair value estimates are completed, therefore, current estimates of fair value may differ significantly from the amounts presented herein. Items measured at Level 3 fair value on a nonrecurring basis – The following table presents financial assets and liabilities measured at fair value on a nonrecurring basis that are classified within Level 3 of the fair value hierarchy at the dates indicated:
| Level 1 |  | Level 2 |  | Level 3 |  | Total Fair Value
| (dollars in thousands; unaudited)
June 30, 2026 |  |  |  |  |  |  |
Collateral dependent loans | $ | — |  |  | $ | — |  |  | $ | 19 |  |  | $ | 19 |
Equity securities | $ | — |  |  | $ | — |  |  | $ | 1,821 |  |  | $ | 1,821 |
Total | $ | — |  |  | $ | — |  |  | $ | 1,840 |  |  | $ | 1,840 |
December 31, 2025 |  |  |  |  |  |  |
Collateral dependent loans | $ | — |  |  | $ | — |  |  | $ | 97 |  |  | $ | 97 |
Equity securities | — |  |  | — |  |  | 2,171 |  |  | 2,171 |
Total | $ | — |  |  | $ | — |  |  | $ | 2,268 |  |  | $ | 2,268 |
The amounts disclosed above represent the fair values at the time the nonrecurring fair value measurements were made, and not necessarily the fair value as of the dates reported on. Collateral dependent loans - Fair values for individually evaluated collateral dependent loans are estimated using the fair value of the collateral less selling costs if the loan results in a Level 3 classification. Individually evaluated loan amounts are initially valued at the lower of cost or fair value. Individually evaluated loans carried at fair value generally receive specific allocations of the allowance for credit losses. For collateral dependent real estate loans, fair value is commonly based on recent real estate appraisals. These appraisals may utilize a single valuation approach or a combination of approaches including comparable sales and the income approach. Adjustments are routinely made in the appraisal process by the independent appraisers to adjust for differences between the comparable sales and income data available. Such adjustments are usually significant and typically result in a Level 3 classification of the inputs for determining fair value. Non-real estate collateral may be valued using an appraisal, net book value per the borrower’s financial statements, or aging reports, adjusted or discounted based on management’s historical knowledge, changes in market conditions from the time of the valuation, and management’s expertise and knowledge of the client and client’s business, resulting in a Level 3 fair value classification. Individually evaluated loans are evaluated on a quarterly basis for additional credit losses and adjusted accordingly. The estimated fair values of financial instruments disclosed above follow the guidance in ASU 2016-01 which prescribes an “exit price” approach in estimating and disclosing fair value of financial instruments incorporating discounts for credit, liquidity and marketability factors. Valuation is measured based on the fair value of the underlying collateral or the discounted cash expected future cash flows. Subsequent changes in the value of loans are included within the provision for credit losses on loans in the same manner in which it initially was recognized or as a reduction in the provision that would otherwise be reported. Loans are evaluated quarterly to determine if valuation adjustments should be recorded. The need for valuation adjustments arises when observable market prices or current appraised values of collateral indicate a shortfall in collateral value compared to current carrying values of the related loan. If the Company determines that the value of the individually evaluated loan is less than the carrying value of the loan, the Company either establishes a reserve as a specific component of the allowance for credit losses or charges off that amount. These valuation adjustments are considered nonrecurring fair value adjustments. Equity securities – The Company measures equity securities without readily determinable fair values at cost less impairment (if any), plus or minus observable price changes from an identical or similar investment of the same issuer, with price changes recognized in earnings. Equity securities without readily determinable fair values The following table presents the carrying value of equity securities without readily determinable fair values, as of June 30, 2026, with adjustments recorded during the periods presented for those securities with observable price changes, if applicable. These equity securities are included in other investments on the balance sheet. •The Company had a $1.8 million equity interest in a specialized bank technology company as of the quarters ended June 30, 2026 and 2025. •The Company had a $350,000 equity interest in a technology company as of the quarters ended June 30, 2026 and 2025. •The Company had a $500,000 equity interest in financial technology company as of the quarter ended June 30, 2026. This was a new equity investment for 2026. •The Company had a $42,000 and $47,000 equity interest in a technology company as of the quarters ended June 30, 2026 and 2025, respectively.
|  | For the Three Months Ended June 30, |  | For the Six Months Ended June 30,
(dollars in thousands; unaudited) |  | 2026 |  | 2025 |  | 2026 |  | 2025
Carrying value, beginning of period |  | $ | 2,671 |  |  | $ | 2,619 |  |  | $ | 2,171 |  |  | $ | 2,619 |
Purchases |  | — |  |  | — |  |  | 500 |  |  | — |
Observable price change |  | — |  |  | (443) |  |  | — |  |  | (443) |
Carrying value, end of period |  | $ | 2,671 |  |  | $ | 2,176 |  |  | $ | 2,671 |  |  | $ | 2,176 |
The following table provides a description of the valuation technique, unobservable inputs, and qualitative information about the unobservable inputs for the Company’s assets and liabilities classified as Level 3 and measured at fair value on a nonrecurring basis at the date indicated:
(unaudited) |  | Valuation Technique |  | Unobservable Inputs |  | June 30, 2026 Weighted Average Rate |  | December 31, 2025 Weighted Average Rate
Collateral dependent loans |  | Collateral valuations |  | Discount to appraised value |  | 8.4% |  | 8.1%

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 107 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 100 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2E -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 940 -SubTopic 820 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration